160 related articles for article (PubMed ID: 23403296)
1. Olive secoiridoids and semisynthetic bioisostere analogues for the control of metastatic breast cancer.
Busnena BA; Foudah AI; Melancon T; El Sayed KA
Bioorg Med Chem; 2013 Apr; 21(7):2117-27. PubMed ID: 23403296
[TBL] [Abstract][Full Text] [Related]
2. Extra-virgin olive oil polyphenols inhibit HER2 (erbB-2)-induced malignant transformation in human breast epithelial cells: relationship between the chemical structures of extra-virgin olive oil secoiridoids and lignans and their inhibitory activities on the tyrosine kinase activity of HER2.
Menendez JA; Vazquez-Martin A; Oliveras-Ferraros C; Garcia-Villalba R; Carrasco-Pancorbo A; Fernandez-Gutierrez A; Segura-Carretero A
Int J Oncol; 2009 Jan; 34(1):43-51. PubMed ID: 19082476
[TBL] [Abstract][Full Text] [Related]
3. The indole alkaloid meleagrin, from the olive tree endophytic fungus Penicillium chrysogenum, as a novel lead for the control of c-Met-dependent breast cancer proliferation, migration and invasion.
Mady MS; Mohyeldin MM; Ebrahim HY; Elsayed HE; Houssen WE; Haggag EG; Soliman RF; El Sayed KA
Bioorg Med Chem; 2016 Jan; 24(2):113-22. PubMed ID: 26692349
[TBL] [Abstract][Full Text] [Related]
4. Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models.
Akl MR; Ayoub NM; Mohyeldin MM; Busnena BA; Foudah AI; Liu YY; Sayed KA
PLoS One; 2014; 9(5):e97622. PubMed ID: 24849787
[TBL] [Abstract][Full Text] [Related]
5. The oleocanthal-based homovanillyl sinapate as a novel c-Met inhibitor.
Mohyeldin MM; Akl MR; Ebrahim HY; Dragoi AM; Dykes S; Cardelli JA; El Sayed KA
Oncotarget; 2016 May; 7(22):32247-73. PubMed ID: 27086914
[TBL] [Abstract][Full Text] [Related]
6. (-)-Oleocanthal as a c-Met inhibitor for the control of metastatic breast and prostate cancers.
Elnagar AY; Sylvester PW; El Sayed KA
Planta Med; 2011 Jul; 77(10):1013-9. PubMed ID: 21328179
[TBL] [Abstract][Full Text] [Related]
7. Optimization, pharmacophore modeling and 3D-QSAR studies of sipholanes as breast cancer migration and proliferation inhibitors.
Foudah AI; Sallam AA; Akl MR; El Sayed KA
Eur J Med Chem; 2014 Feb; 73():310-24. PubMed ID: 24487236
[TBL] [Abstract][Full Text] [Related]
8. Novel c-Met inhibitory olive secoiridoid semisynthetic analogs for the control of invasive breast cancer.
Mohyeldin MM; Busnena BA; Akl MR; Dragoi AM; Cardelli JA; El Sayed KA
Eur J Med Chem; 2016 Aug; 118():299-315. PubMed ID: 27258622
[TBL] [Abstract][Full Text] [Related]
9. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
10. (1S,2E,4S,7E,11E)-2,7,11-Cembratriene-4,6-diol semisynthetic analogs as novel c-Met inhibitors for the control of c-Met-dependent breast malignancies.
Ebrahim HY; Mohyeldin MM; Hailat MM; El Sayed KA
Bioorg Med Chem; 2016 Nov; 24(22):5748-5761. PubMed ID: 27681240
[TBL] [Abstract][Full Text] [Related]
11. Optimization of marine triterpene sipholenols as inhibitors of breast cancer migration and invasion.
Foudah AI; Jain S; Busnena BA; El Sayed KA
ChemMedChem; 2013 Mar; 8(3):497-510. PubMed ID: 23404739
[TBL] [Abstract][Full Text] [Related]
12. Analyzing effects of extra-virgin olive oil polyphenols on breast cancer-associated fatty acid synthase protein expression using reverse-phase protein microarrays.
Menendez JA; Vazquez-Martin A; Oliveras-Ferraros C; Garcia-Villalba R; Carrasco-Pancorbo A; Fernandez-Gutierrez A; Segura-Carretero A
Int J Mol Med; 2008 Oct; 22(4):433-9. PubMed ID: 18813848
[TBL] [Abstract][Full Text] [Related]
13. Redox-silent tocotrienol esters as breast cancer proliferation and migration inhibitors.
Behery FA; Elnagar AY; Akl MR; Wali VB; Abuasal B; Kaddoumi A; Sylvester PW; El Sayed KA
Bioorg Med Chem; 2010 Nov; 18(22):8066-75. PubMed ID: 20943398
[TBL] [Abstract][Full Text] [Related]
14. Secoiridoids of olive and derivatives as potential coadjuvant drugs in cancer: A critical analysis of experimental studies.
Celano M; Maggisano V; Lepore SM; Russo D; Bulotta S
Pharmacol Res; 2019 Apr; 142():77-86. PubMed ID: 30772463
[TBL] [Abstract][Full Text] [Related]
15. Potential Uses of Olive Oil Secoiridoids for the Prevention and Treatment of Cancer: A Narrative Review of Preclinical Studies.
Emma MR; Augello G; Di Stefano V; Azzolina A; Giannitrapani L; Montalto G; Cervello M; Cusimano A
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513799
[TBL] [Abstract][Full Text] [Related]
16. Crude phenolic extracts from extra virgin olive oil circumvent de novo breast cancer resistance to HER1/HER2-targeting drugs by inducing GADD45-sensed cellular stress, G2/M arrest and hyperacetylation of Histone H3.
Oliveras-Ferraros C; Fernández-Arroyo S; Vazquez-Martin A; Lozano-Sánchez J; Cufí S; Joven J; Micol V; Fernández-Gutiérrez A; Segura-Carretero A; Menendez JA
Int J Oncol; 2011 Jun; 38(6):1533-47. PubMed ID: 21455577
[TBL] [Abstract][Full Text] [Related]
17. A Systematic Ex-Vivo Study of the Anti-Proliferative/Cytotoxic Bioactivity of Major Olive Secoiridoids' Double Combinations and of Total Olive Oil Phenolic Extracts on Multiple Cell-Culture Based Cancer Models Highlights Synergistic Effects.
Papakonstantinou A; Koumarianou P; Diamantakos P; Melliou E; Magiatis P; Boleti H
Nutrients; 2023 May; 15(11):. PubMed ID: 37299499
[TBL] [Abstract][Full Text] [Related]
18. New Affordable Methods for Large-Scale Isolation of Major Olive Secoiridoids and Systematic Comparative Study of Their Antiproliferative/Cytotoxic Effect on Multiple Cancer Cell Lines of Different Cancer Origins.
Papakonstantinou A; Koumarianou P; Rigakou A; Diamantakos P; Frakolaki E; Vassilaki N; Chavdoula E; Melliou E; Magiatis P; Boleti H
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613449
[TBL] [Abstract][Full Text] [Related]
19. The differential localization of a methyl group confers a different anti-breast cancer activity to two triterpenes present in olives.
Sánchez-Quesada C; López-Biedma A; Gaforio JJ
Food Funct; 2015 Jan; 6(1):249-56. PubMed ID: 25412049
[TBL] [Abstract][Full Text] [Related]
20. Chronic exposure to fulvestrant promotes overexpression of the c-Met receptor in breast cancer cells: implications for tumour-stroma interactions.
Hiscox S; Jordan NJ; Jiang W; Harper M; McClelland R; Smith C; Nicholson RI
Endocr Relat Cancer; 2006 Dec; 13(4):1085-99. PubMed ID: 17158755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
